The Significance of Ku70 Expression in Patients with Nasopharyngeal Carcinoma.
- Author:
Si Yeol SONG
1
;
Sang Wook LEE
;
Eunsil YU
;
Kyung Ja CHO
;
Jin Hong PARK
;
Sang Yoon KIM
;
Soon Yuhl NAM
;
Bong Jae LEE
;
Sung Bae KIM
;
Seung Ho CHOI
;
Seung Do AHN
;
Seong Soo SHIN
;
Eun Kyung CHOI
;
Jong Hoon KIM
Author Information
1. Departments of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. lsw@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Chemotherapy;
DNA-PKcs;
Immunohistochemistry;
Nasopahryngeal carcinoma;
Radiotherapy;
Ku70
- MeSH:
Biopsy;
DNA-Activated Protein Kinase;
Drug Therapy;
Humans;
Immunohistochemistry;
Radiotherapy;
Recurrence;
Retrospective Studies;
Survival Rate
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2005;23(1):1-8
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The objective of this study was to determine whether the expressions of the two components of DNA-dependent protein kinase, Ku70 and DNA-PKcs, influence the response to radiotherapy (RT) and outcome of treatment of non-disseminated nasopharyngeal carcinoma (NPC) in patients who received definitive RT. MATERIASL AND METHODS: Sixty-six patients with NPC who were treated with radiotherapy alone or with concurrent chemotherapy between June 1995 and December 2001 were divided into groups based on the levels of immunoreactivity for Ku70 and DNA-PKcs in pretreatment biopsy specimens. The over-expression of Ku70 or DNA-PKcs groups included patients whose biopsy specimens showed at least 50% immunopositive tumor cells; patients in which less than 50% of the tumor cells in the biopsy tissues were immunopositive were placed in the low Ku70 and DNA-PKcs groups. The immunoreactivities for Ku70 and DNA-PKcs were retrospectively compared with the sensitivity of the tumor to radiation and the patterns of therapy failure. Univariate analyses were performed to determine the prognostic factors that influenced locoregional control of NPC. RESULTS: The five-year locoregional control rate was significantly higher in the low Ku70 group (Ku(-)) (85%) than in the high Ku70 group (Ku(+)) (42%) (p=0.0042). However, there were no differences in the metastases-free survival rates between the two groups (Ku70 (+), 82%; Ku70 (-), 78%; p=0.8672). Univariate analysis indicated that the over-expression of Ku70 surpassed other well-known predictive clinocopathologic parameters as an independent prognostic factor for locoregional control. Eighteen of 22 patients who had locoregional recurrences of the tumor displayed an over-expression of Ku70. No significant association was found between the level of DNA-PKcs expression and the clinical outcome. CONCLUSION: Our data suggest that the level of Ku70 expression can be used as a molecular marker to predict the response to RT and the locoregional control after RT and concurrent chemotherapy in patients with non-disseminated NPC.
